Introduce Fostamatinib in Mouth/Phar, Extern, New Tech 7

This code describes the administration of fostamatinib, an oral medication, directly into the patient's mouth and pharynx. This procedure is performed via an external approach, meaning the medication is ingested or delivered orally without surgical incision. The "New Technology Group 7" designation indicates that this specific drug and its administration method are considered innovative and are being tracked for data collection purposes.

This code is used when a patient receives fostamatinib orally for conditions such as chronic immune thrombocytopenia (ITP), where it is indicated to increase platelet counts. It applies to inpatient encounters where the medication is administered and documented as part of the patient's treatment plan. This code would be appropriate for the initial or subsequent oral administration of fostamatinib during an inpatient stay.